New York, NY – Square 1 Bank proudly announces the extension of a $6 million senior facility to Validus Pharmaceuticals LLC, a specialty pharmaceutical company focused on the acquisition and commercialization of effective branded and underutilized products in specialty therapeutic areas. Based in Parsippany, NJ, Validus’ product portfolio currently consists of Marplan®, Equetro®, and Rocaltrol®.
“We were impressed with Square 1’s commitment to the relationship,” stated Validus’ CEO, James Hunter. “They truly understood our unique position in the marketplace and provided the flexibility needed for our company’s growth needs.”
“Validus has a strong platform in place with a great leadership team. We are thrilled to partner with a company that is equally as dedicated to innovation and growth as Square 1,” said Dan Lee, SVP and Managing Director of Square 1’s Growth Finance group.
About Validus Pharmaceuticals
Validus Pharmaceuticals is a specialty pharmaceutical company founded in
Parsippany, NJ in 2007 to serve the unmet needs of patients in specialty
therapeutic areas. The company pursues this mission with targeted and focused
marketing efforts and active acquisition and in-licensing programs aimed at
underutilized specialty products that have important future potential. Please
log-on to www.validuspharma.com for
About Square 1
Square 1 Bank is a full service commercial bank dedicated exclusively to serving the financial needs of the venture capital community and entrepreneurs in all stages of growth and expansion. Square 1's expertise, focus and strong capital base provide solid support for its clients' needs. The bank offers tailored products and solutions aided by the latest in technological innovations. To serve its relationships, Square 1 has offices coast to coast in Austin, Boston, Boulder, Durham, McLean, New York, San Diego, Santa Monica, Seattle, and Silicon Valley. For more information, visit www.square1bank.com.
Back To Press and Events